https://www.reuters.com/business/healthcare-pharmaceuticals/uk-probing-novos-ozempic-weight-loss-drug-saxenda-over-suicidal-self-harming-2023-07-26/
0
0
7/26/23 at 1:33pm
Organization
Reuters
Author
Maggie Fick
Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> after some patients reported suicidal or self-harmin…
Create an account
or login to join the discussion